HIGHLIGHTS
- who: Tien-Hua Chen from the Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan have published the article: Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma, in the Journal: (JOURNAL)
- what: The aim of this study was to explore the treatment outcomes of cetuximabcontaining regimen in recurrent and metastatic SCCHN groups and to identify clinical factors correlated with better survival outcomes. Exploratory analysis were conducted to investigate major clinical features associated with better outcomes. In this study, the efficacy of cetuximab . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.